X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with Strides Arcolab - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs STRIDES SHASUN LTD - Comparison Results

STRIDES SHASUN LTD 
   Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES STRIDES SHASUN LTD ALKEM LABORATORIES/
STRIDES SHASUN LTD
 
P/E (TTM) x - 14.1 - View Chart
P/BV x 6.1 1.9 322.1% View Chart
Dividend Yield % 0.7 0.5 129.2%  

Financials

 ALKEM LABORATORIES   STRIDES SHASUN LTD
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
STRIDES SHASUN LTD
Mar-16
ALKEM LABORATORIES/
STRIDES SHASUN LTD
5-Yr Chart
Click to enlarge
High Rs1,5891,413 112.5%   
Low Rs1,232848 145.3%   
Sales per share (Unadj.) Rs417.5353.3 118.2%  
Earnings per share (Unadj.) Rs56.323.4 240.7%  
Cash flow per share (Unadj.) Rs64.741.0 157.9%  
Dividends per share (Unadj.) Rs12.705.00 254.0%  
Dividend yield (eoy) %0.90.4 203.5%  
Book value per share (Unadj.) Rs292.9320.4 91.4%  
Shares outstanding (eoy) m119.5789.35 133.8%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x3.43.2 105.6%   
Avg P/E ratio x25.148.3 51.8%  
P/CF ratio (eoy) x21.827.6 79.0%  
Price / Book Value ratio x4.83.5 136.5%  
Dividend payout %22.621.4 105.5%   
Avg Mkt Cap Rs m168,653100,988 167.0%   
No. of employees `000NA4.7 0.0%   
Total wages/salary Rs m9,1714,988 183.9%   
Avg. sales/employee Rs ThNM6,730.0-  
Avg. wages/employee Rs ThNM1,063.6-  
Avg. net profit/employee Rs ThNM445.5-  
INCOME DATA
Net Sales Rs m49,91531,564 158.1%  
Other income Rs m1,6451,212 135.7%   
Total revenues Rs m51,56132,776 157.3%   
Gross profit Rs m8,4825,213 162.7%  
Depreciation Rs m1,0061,573 63.9%   
Interest Rs m6711,803 37.2%   
Profit before tax Rs m8,4513,049 277.2%   
Minority Interest Rs m-114127 -89.9%   
Prior Period Items Rs m0-27 0.0%   
Extraordinary Inc (Exp) Rs m0-371 0.0%   
Tax Rs m1,606689 233.2%   
Profit after tax Rs m6,7312,089 322.2%  
Gross profit margin %17.016.5 102.9%  
Effective tax rate %19.022.6 84.2%   
Net profit margin %13.56.6 203.7%  
BALANCE SHEET DATA
Current assets Rs m27,06235,949 75.3%   
Current liabilities Rs m15,32419,402 79.0%   
Net working cap to sales %23.552.4 44.9%  
Current ratio x1.81.9 95.3%  
Inventory Days Days6771 93.8%  
Debtors Days Days41127 32.6%  
Net fixed assets Rs m12,61034,478 36.6%   
Share capital Rs m239894 26.8%   
"Free" reserves Rs m34,49022,601 152.6%   
Net worth Rs m35,02728,632 122.3%   
Long term debt Rs m1,21227,455 4.4%   
Total assets Rs m54,38776,591 71.0%  
Interest coverage x13.62.7 505.5%   
Debt to equity ratio x01.0 3.6%  
Sales to assets ratio x0.90.4 222.7%   
Return on assets %13.65.1 267.8%  
Return on equity %19.27.3 263.3%  
Return on capital %24.98.2 304.3%  
Exports to sales %12.948.1 26.9%   
Imports to sales %3.114.5 21.3%   
Exports (fob) Rs m6,46115,192 42.5%   
Imports (cif) Rs m1,5404,565 33.7%   
Fx inflow Rs m6,56316,612 39.5%   
Fx outflow Rs m3,0125,292 56.9%   
Net fx Rs m3,55211,320 31.4%   
CASH FLOW
From Operations Rs m7,259717 1,012.9%  
From Investments Rs m1,864-22,284 -8.4%  
From Financial Activity Rs m-9,27329,488 -31.4%  
Net Cashflow Rs m-1508,073 -1.9%  

Share Holding

Indian Promoters % 66.9 27.7 241.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 33.1 37.8 87.6%  
FIIs % 0.0 8.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 25.9 -  
Shareholders   68,381 56,241 121.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   BIOCON LTD  CADILA HEALTHCARE  SUVEN LIFE  PANACEA BIOTECH  GLENMARK PHARMA  

Compare ALKEM LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


Aug 23, 2017 (Close)

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES 5-YR ANALYSIS

COMPARE ALKEM LABORATORIES WITH

MARKET STATS